Where the blockbuster weight loss drug market stands today — and what’s coming next
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...
Tag: Hims & Hers Health Inc
Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the ...
Hims & Hers to acquire European telehealth platform in global expansion
The Hims logo arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. Bloomberg | Bloomberg | Getty ...
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 18%
The "Wegovy" brand slimming syringe is sold in the Achat pharmacy in Mitte. The "Wegovy" slimming syringe has been available ...
Hims & Hers shares rise as company adds new weight-loss medications to platform
The Hims app arranged on a smartphone in New York on Feb. 12, 2025.Gabby Jones | Bloomberg | Getty ImagesHims ...
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound ...
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings ...
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA says
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersThe long-running U.S. shortage ...
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced ...
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients
Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings that's slated to run ...
